Australia markets open in 57 minutes

Universe Pharmaceuticals INC (UPC)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
0.8448-0.1152 (-12.00%)
At close: 03:58PM EST
0.8010 -0.04 (-5.18%)
After hours: 04:19PM EST

Universe Pharmaceuticals INC

No. 265, Jingjiu Avenue
Jinggangshan Eco and Tech Dev Zn
Ji'An 343100
86 79 6840 3309

IndustryDrug Manufacturers - Specialty & Generic
Full-time employees224

Key executives

NameTitlePayExercisedYear born
Mr. Gang LaiCEO & ChairmanN/AN/A1968
Ms. Lin YangCFO & DirectorN/AN/A1976
Mr. Baochang LiuChief Operating OfficerN/AN/A1980
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Universe Pharmaceuticals INC, a pharmaceutical company, engages in the development, manufacturing, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

Corporate governance

Universe Pharmaceuticals INC’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.